EUVIMEDEUVIMED entdecken
Klinische Studie (Phase II)Randomisierte kontrollierte Studie

Neuroprotective Effects of Inhaled Xenon Gas on Brain Structural Gray Matter Changes After Out-of-Hospital Cardiac Arrest Evaluated by Morphometric Analysis: A Substudy of the Randomized Xe-Hypotheca Trial

Carita Hollmén, Riitta Parkkola, Victor Vorobyev, Jani Saunavaara, Ruut Laitio, Olli Arola, Marja Hynninen, Minna Bäcklund, Juha Martola, Emmi Ylikoski, Risto O Roine, Marjaana Tiainen und 4 weitere

Neurocritical Care · 2025

DOI: 10.1007/s12028-024-02053-8 ↗

Kurz gefasst

Klinische Studie (Phase II) in der Zeitschrift Neurocritical Care, 2025. Verfasst von Carita Hollmén und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Turku University Hospital, University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Coma, Gray Matter, Hypothermia, Induced, Neuroprotective Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: State Research Funding, Finland, Academy of Finland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We have earlier reported that inhaled xenon combined with hypothermia attenuates brain white matter injury in comatose survivors of out-of-hospital cardiac arrest (OHCA). A predefined secondary objective was to assess the effect of inhaled xenon on the structural changes in gray matter in comatose survivors after OHCA. METHODS: Patients were randomly assigned to receive either inhaled xenon combined with target temperature management (33 °C) for 24 h (n = 55, xenon group) or target temperature management alone (n = 55, control group). A change of brain gray matter volume was assessed with a voxel-based morphometry evaluation of high-resolution structural brain magnetic resonance imaging (MRI) data with Statistical Parametric Mapping. Patients were scheduled to undergo the first MRI between 36 and 52 h and a second MRI 10 days after OHCA. RESULTS: Of the 110 randomly assigned patients in the Xe-Hypotheca trial, 66 patients completed both MRI scans. After all imaging-based exclusions, 21 patients in the control group and 24 patients in the xenon group had both scan 1 and scan 2 available for analyses with scans that fulfilled the quality criteria. Compared with the xenon group, the control group had a significant decrease in brain gray matter volume in several clusters in the second scan compared with the first. In a between-group analysis, significant reductions were found in the right amygdala/entorhinal cortex (p = 0.025), left amygdala (p = 0.043), left middle temporal gyrus (p = 0.042), left inferior temporal gyrus (p = 0.008), left parahippocampal gyrus (p = 0.042), left temporal pole (p = 0.042), and left cerebellar cortex (p = 0.005). In the remaining gray matter areas, there were no significant changes between the groups. CONCLUSIONS: In comatose survivors of OHCA, inhaled xenon combined with targeted temperature management preserved gray matter better than hypothermia alone. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: NCT00879892.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ComaGray MatterHypothermia, InducedNeuroprotective AgentsOut-of-Hospital Cardiac ArrestXenonAdultAgedFemaleHumansMaleMiddle AgedAdministration, InhalationMagnetic Resonance Imaging

Stichwörter der Autor:innen

Gray matter injuryNeuroprotectionOut-of-hospital cardiac arrestTargeted temperature managementVoxel-based morphometryXenon

Substanzen

Neuroprotective AgentsXenon

Autor:innen und Institutionen

  • Department of Radiology, Turku University Hospital, University of Turku, Turku, Finland.
  • Department of Medical Physics, Turku University Hospital, University of Turku, Turku, Finland.
  • Division of Perioperative Services, Intensive Care Medicine and Pain Management, Turku University Hospital, University of Turku, POB 52, 20521, Turku, Finland.
  • Division of Intensive Care Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Department of Radiology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Division of Clinical Neurosciences, Turku University Hospital, University of Turku, Turku, Finland.

ORCID-Profile: Timo T Laitio

Förderung

  • State Research Funding, Finland
  • Academy of Finland

Zitieren

APA

Hollmén, C., Parkkola, R., Vorobyev, V., Saunavaara, J., Laitio, R., Arola, O., Hynninen, M., Bäcklund, M., Martola, J., Ylikoski, E., Roine, R. O., Tiainen, M., Scheinin, H., Maze, M., Vahlberg, T., & Laitio, T. T. (2025). Neuroprotective Effects of Inhaled Xenon Gas on Brain Structural Gray Matter Changes After Out-of-Hospital Cardiac Arrest Evaluated by Morphometric Analysis: A Substudy of the Randomized Xe-Hypotheca Trial. Neurocritical Care. https://doi.org/10.1007/s12028-024-02053-8

Vancouver

Hollmén C, Parkkola R, Vorobyev V, Saunavaara J, Laitio R, Arola O, et al. Neuroprotective Effects of Inhaled Xenon Gas on Brain Structural Gray Matter Changes After Out-of-Hospital Cardiac Arrest Evaluated by Morphometric Analysis: A Substudy of the Randomized Xe-Hypotheca Trial. Neurocritical Care. 2025. doi:10.1007/s12028-024-02053-8

BibTeX
@article{Hollmn2025,
  author = {Hollmén, Carita and Parkkola, Riitta and Vorobyev, Victor and Saunavaara, Jani and Laitio, Ruut and Arola, Olli and Hynninen, Marja and Bäcklund, Minna and Martola, Juha and Ylikoski, Emmi and Roine, Risto O and Tiainen, Marjaana and Scheinin, Harry and Maze, Mervyn and Vahlberg, Tero and Laitio, Timo T},
  title = {Neuroprotective Effects of Inhaled Xenon Gas on Brain Structural Gray Matter Changes After Out-of-Hospital Cardiac Arrest Evaluated by Morphometric Analysis: A Substudy of the Randomized Xe-Hypotheca Trial},
  journal = {Neurocritical Care},
  year = {2025},
  doi = {10.1007/s12028-024-02053-8}
}
Kostenlos starten →